4.6 Article

The association of idiopathic recurrent pregnancy loss with polymorphisms in hemostasis-related genes

Journal

GENE
Volume 530, Issue 2, Pages 248-252

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.gene.2013.07.080

Keywords

Antithrombin; Thrombomodulin; Tissue factor pathway inhibitor; Factor V; Factor II; Annexin A5

Funding

  1. Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-06]
  2. National Basic Research Program of China (973 program) [2010CB529505]

Ask authors/readers for more resources

Recurrent pregnancy loss (RPL) is a complex, multifactorial condition. Inherited thrombophilia is the leading cause of thromboembolism and is associated with an increased risk of RPL The aims of the current study were to investigate the effects of polymorphisms in hemostasis-related genes antithrombin (SERPINC1), thrombomodulin (THBD), tissue factor pathway inhibitor (TFPI), factor V, factor II and annexin A5 (ANXA5), involved in reproductive failure in 94 RPL cases with two or more consecutive pregnancy losses prior to 20 weeks of pregnancy and 169 healthy controls who had at least one term delivery and no history of pregnancy loss. The genotypes of SERPINC1 G786A, THBD C1418T, TFPI T-33C, factor V G1628A, factor II A19911G and ANXA5 G76A were assayed by the Sequenom MassARRAY system. Genotype and allele frequencies for SERPINC1 (rs2227589), TFPI (rs8176592), factor V (rs6020), factor II (rs3136516) and ANXA5 (rs113588187) in cases and controls were similar. The distribution of THBD C1418T allele showed significant differences between RPL cases and healthy controls (odds ratio (OR): 158,95%, confidence interval (CI): 1.05-2.39, P = 0.027). In univariate logistic regression analyses, carriers of THBD 1418T allele (CT + TT) had an increased risk of RPL (OR: 1.83, 95%, CI: 1.10-3.06, P = 0.020). This indicated that THBD 1418T allele was associated with increasing the risk of RPL (c) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available